Balanced news tone
News Sentiment
6622 sentiment intelligence
Zhaoke Ophthalmology Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
66/100 classification confidence.
directly relevant articles
high-authority source matches
+1.5% over one week, -7.3% over four weeks, trend inactive, and near fair-value range.
Zhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK002
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Zhaoke Ophthalmology Secures Global Rights to Pediatric Myopia Drug NVK002
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 09:11
- Source
- TipRanks
Zhaoke Ophthalmology Wins Boao Approval for First Innovative Presbyopia Drug in China
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 07 Jul 2026 04:11
- Source
- TipRanks
Visus Therapeutics, Inc., and Zhaoke Ophthalmology Limited Announce Exclusive Licensing Agreement to Commercialize BRIMOCHOL™ PF and Carbachol PF in Greater China, South Korea and Select Southeast Asian Markets for the Treatment of Presbyopi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2022 07:00
- Source
- Business Wire